CytoDyn (CYDY) Debt Ratio (2011 - 2025)
CytoDyn (CYDY) posted Debt Ratio of 3.04 for Q4 2025, up 50.9% on a QoQ basis from 2.02 in Q3 2025, and up 165.43% year-over-year from 1.15 in Q4 2024.
CytoDyn (CYDY) Debt Ratio (2011 - 2025) Analysis & Trends
CytoDyn's Debt Ratio history runs 10 years deep, the most recent figure standing at 3.04 for Q4 2025.
- Quarterly Debt Ratio rose 165.43% year-over-year to 3.04 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was 3.04 (up 165.43% YoY) and the FY2025 annual result came in at 1.51, down 43.66% from the prior year.
- Debt Ratio was 3.04 for Q4 2025 at CytoDyn, up from 2.02 in the prior quarter.
- Across five years, Debt Ratio topped out at 5.22 in Q4 2022 and bottomed at 0.33 in Q1 2021.
- A 5-year average of 1.87 and a median of 1.4 in 2022 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio soared 1131.89% — and 2024, when it plunged 67.8%.
- CytoDyn's Debt Ratio stood at 0.42 in 2021, then surged by 1131.89% to 5.22 in 2022, then slumped by 31.77% to 3.56 in 2023, then sank by 67.8% to 1.15 in 2024, then surged by 165.43% to 3.04 in 2025.
- Business Quant data shows CYDY's Debt Ratio at 3.04 in Q4 2025, 2.02 in Q3 2025, and 1.51 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 3.04 |
| Aug 31, 2025 | 2.02 |
| May 31, 2025 | 1.51 |
| Feb 28, 2025 | 1.28 |
| Nov 30, 2024 | 1.15 |
| Aug 31, 2024 | 1.03 |
| May 31, 2024 | 2.68 |
| Feb 29, 2024 | 2.94 |
| Nov 30, 2023 | 3.56 |
| Aug 31, 2023 | 2.67 |
| May 31, 2023 | 3.11 |
| Feb 28, 2023 | 2.46 |
| Nov 30, 2022 | 5.22 |
| Aug 31, 2022 | 1.30 |
| May 31, 2022 | 1.24 |
| Feb 28, 2022 | 0.38 |
| Nov 30, 2021 | 0.42 |
| Aug 31, 2021 | 0.49 |
| May 31, 2021 | 0.48 |
| Feb 28, 2021 | 0.33 |